ID29315A - Proses-proses untuk membuat penghambat-penghambat 5-lipoksigenase yang memiliki sistem cincin heterosiklik yang bervariasi - Google Patents

Proses-proses untuk membuat penghambat-penghambat 5-lipoksigenase yang memiliki sistem cincin heterosiklik yang bervariasi

Info

Publication number
ID29315A
ID29315A IDP20000718D ID20000718D ID29315A ID 29315 A ID29315 A ID 29315A ID P20000718 D IDP20000718 D ID P20000718D ID 20000718 D ID20000718 D ID 20000718D ID 29315 A ID29315 A ID 29315A
Authority
ID
Indonesia
Prior art keywords
obstaclers
lipoxxigenase
heterosiclic
varied
processes
Prior art date
Application number
IDP20000718D
Other languages
English (en)
Indonesian (id)
Inventor
Timothy Norris
Megan Elizabeth Hnatow
John Francis Lambert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID29315A publication Critical patent/ID29315A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IDP20000718D 1999-08-31 2000-08-29 Proses-proses untuk membuat penghambat-penghambat 5-lipoksigenase yang memiliki sistem cincin heterosiklik yang bervariasi ID29315A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161199P 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
ID29315A true ID29315A (id) 2001-08-16

Family

ID=22539515

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000718D ID29315A (id) 1999-08-31 2000-08-29 Proses-proses untuk membuat penghambat-penghambat 5-lipoksigenase yang memiliki sistem cincin heterosiklik yang bervariasi

Country Status (19)

Country Link
US (1) US6344563B1 (ru)
EP (1) EP1081146A1 (ru)
JP (1) JP2001106687A (ru)
KR (1) KR20010050224A (ru)
CN (1) CN1291609A (ru)
AR (1) AR022649A1 (ru)
AU (1) AU5360700A (ru)
BR (1) BR0003875A (ru)
CA (1) CA2317001A1 (ru)
CZ (1) CZ20003160A3 (ru)
HU (1) HUP0003438A3 (ru)
ID (1) ID29315A (ru)
IL (1) IL138088A0 (ru)
MX (1) MXPA00008505A (ru)
PL (1) PL342284A1 (ru)
RU (1) RU2177005C1 (ru)
TR (1) TR200002523A2 (ru)
YU (1) YU52800A (ru)
ZA (1) ZA200004436B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2398093T3 (es) * 2000-03-24 2013-03-13 Euro-Celtique S.A. Pirazoles, triazoles y tetrazoles sustituidos con arilo como bloqueantes de los canales de sodio
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685122B2 (en) * 1993-06-14 1998-01-15 Pfizer Inc. Imidazole lipoxygenase inhibitors
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
US6063928A (en) * 1994-10-18 2000-05-16 Pfizer Inc 5-lipoxygenase inhibitors
SK281577B6 (sk) 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
EP0863905B1 (en) * 1995-09-18 2000-11-29 Pfizer Inc. imidazole lipoxygenase inhibitors

Also Published As

Publication number Publication date
AU5360700A (en) 2001-03-08
EP1081146A1 (en) 2001-03-07
BR0003875A (pt) 2001-12-11
RU2177005C1 (ru) 2001-12-20
HUP0003438A3 (en) 2002-08-28
HU0003438D0 (en) 2000-08-30
YU52800A (sh) 2003-08-29
ZA200004436B (en) 2002-02-28
US6344563B1 (en) 2002-02-05
AR022649A1 (es) 2002-09-04
CN1291609A (zh) 2001-04-18
PL342284A1 (en) 2001-03-12
IL138088A0 (en) 2001-10-31
JP2001106687A (ja) 2001-04-17
CZ20003160A3 (cs) 2001-10-17
HUP0003438A2 (hu) 2001-08-28
TR200002523A2 (tr) 2001-04-20
CA2317001A1 (en) 2001-02-28
MXPA00008505A (es) 2005-07-25
KR20010050224A (ko) 2001-06-15

Similar Documents

Publication Publication Date Title
ID25779A (id) Sistem integrasi aplikasi perusahaan yang terdistribusi yang dapat diperluas
ID23194A (id) Sistem komunikasi seluler yang ditingkatkan
GB2346097B (en) Retaining ring
AU2002213358A1 (en) Knowledge pattern integration system
ID29556A (id) Sistem telepon-kepala
IL146988A0 (en) Lightweight construction system
GB2349298B (en) Conference communication system
GB2383533B (en) Sprinkler system
DE69910408D1 (de) Steifes Ringteil
ID29315A (id) Proses-proses untuk membuat penghambat-penghambat 5-lipoksigenase yang memiliki sistem cincin heterosiklik yang bervariasi
GB9926225D0 (en) Flood pro-tech system
DE59909604D1 (de) Prothesensystem
GB2370698B (en) Raceway system
ID27129A (id) Proses-proses untuk pembuatan penghambat-penghambat 5-lipoksigenase yang memiliki sistem cincin heterosiklik yang bervariasi
ID27234A (id) Turunan-turunan triazol yang mempunyai aktivitas anti-jamur
ID23257A (id) Sistem antioksidan
GB9912066D0 (en) Communication systems
ID24805A (id) Sistem ekspresi
NO20001643D0 (no) Kommunikasjonssystem
GB0031759D0 (en) Ring protection system
ID27128A (id) Proses pembuatan penghambat 5-lipoksigenase yang memiliki sistem-sistem cincin heterosiklus yang bervariasi
GB2389263B (en) Ring network system
ID28843A (id) Sistem untuk menempatkan telepon bergerak
NO20004230D0 (no) Kommunikasjonssystem
NO20002082L (no) Kommunikasjonssystem